| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | WO2001094584A3 21784, a novel human calcium channel family member and uses thereof |
| 01/16/2003 | WO2001093913A3 T cell receptor fusions and conjugates and methods of use thereof |
| 01/16/2003 | WO2001092549A3 Method and composition for targeting an adenoviral vector |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/16/2003 | WO2001087937A3 G-protein coupled receptors |
| 01/16/2003 | WO2001085941A9 Myc targets |
| 01/16/2003 | WO2001085767A3 Human proteins polynucleotides encoding them and methods of using the same |
| 01/16/2003 | WO2001081375A9 Dna & protein binding miniature proteins |
| 01/16/2003 | WO2001074901A3 Polynucleotides and polypeptides, their use in diagnosis and treatment of cardiac, renal or inflammary disease |
| 01/16/2003 | WO2001074898A3 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 01/16/2003 | WO2001072833A3 Human ephrin-like receptor |
| 01/16/2003 | WO2001071013A3 Melon promoters for expression of transgenes in plants |
| 01/16/2003 | WO2001070980A9 Isolated g-protein coupled receptors, nucleic acid molecules encoding gpcr proteins, and uses thereof as insecticidal targets |
| 01/16/2003 | WO2001070174A8 Vegf-modulated genes and methods employing them |
| 01/16/2003 | WO2001068805A9 Human olfactory receptors and genes encoding same |
| 01/16/2003 | WO2001064944A9 MODULATION OF PLEIOTROPHIN SIGNALING BY RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE β/$g(z) |
| 01/16/2003 | WO2001064913A9 Cell cycle proteins associated with rad9, compositions and methods of use |
| 01/16/2003 | WO2001064882A9 1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor |
| 01/16/2003 | WO2001064880A9 Human dynamin 40322 |
| 01/16/2003 | WO2001059093A9 Full-length infectious cdna clones of tick borne flavivirus |
| 01/16/2003 | WO2001058954A9 Trade molecules and uses related thereto |
| 01/16/2003 | WO2001058946A9 Polynucleotides and polypeptides encoded thereby |
| 01/16/2003 | WO2001055209A9 Novel human septin and uses thereof |
| 01/16/2003 | WO2001053340A9 Transgenic mouse model of human neurodegenerative disease |
| 01/16/2003 | US20030014777 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
| 01/16/2003 | US20030013867 Translation enhancer element of the human amyloid precursor protein gene |
| 01/16/2003 | US20030013866 Eukaryotic cells expressing the receptor |
| 01/16/2003 | US20030013865 Novel human EGF-family proteins and polynucleotides encoding the same |
| 01/16/2003 | US20030013857 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties |
| 01/16/2003 | US20030013855 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013851 Identification, characterization and three dimensional structure of an active site of interleukin-13 (il-13) |
| 01/16/2003 | US20030013850 Antiinflammatory agents |
| 01/16/2003 | US20030013849 Renilla reniformis green fluorescent protein |
| 01/16/2003 | US20030013848 Protein-tyrosine kinase genes |
| 01/16/2003 | US20030013844 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 01/16/2003 | US20030013659 Herpes virus |
| 01/16/2003 | US20030013655 Compounds and methods for regulating cell adhesion |
| 01/16/2003 | US20030013654 Administering polypeptide |
| 01/16/2003 | US20030013652 Releasing moderators for inflammation |
| 01/16/2003 | US20030013651 Stimulation of osteogenesis using rank ligand fusion proteins |
| 01/16/2003 | US20030013650 VR-OAC, an osomotically activated channel protein, nucleic acids encoding it, and uses thereof |
| 01/16/2003 | US20030013649 Hybrid polypeptide |
| 01/16/2003 | US20030013648 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 01/16/2003 | US20030013647 Selenocosmia huwena toxin and analgesic uses thereof |
| 01/16/2003 | US20030013646 Methods to stimulate insulin production by pancreatic beta-cells |
| 01/16/2003 | US20030013642 Hemoglobin-haptoglobin complexes |
| 01/16/2003 | US20030013641 Complexing drug with diketopiperazine; washing; separation of impurities |
| 01/16/2003 | US20030013638 P27 prevents cellular migration |
| 01/16/2003 | US20030013197 Generation of adenovirus associated vector cultures; obtain cells, infect with expression vector, express vector and recover viral particles |
| 01/16/2003 | US20030013171 Nucleotide sequences coding polypeptide for use in treatment or prevention of immune system disorders |
| 01/16/2003 | US20030013170 Inhibitors of receptor activator of NF-kappaB and uses thereof |
| 01/16/2003 | US20030013169 Transcription factor E2F DNA-binding domain inhibitor peptides and their use |
| 01/16/2003 | US20030013162 Interferon-epsilon |
| 01/16/2003 | US20030013161 Nucleotide sequences coding polypeptide for use in the treatment of cancer, allergies, autoimmune and inflammatory disorders |
| 01/16/2003 | US20030013159 Reagents and methods useful for detecting gastrointestinal tract diseases |
| 01/16/2003 | US20030013158 Delta subunit of human GABAA receptor |
| 01/16/2003 | US20030013156 Peptide for use in the treatment of cell prliferation disorders |
| 01/16/2003 | US20030013155 Polypeptide for use in human therapeutics and diagnostics |
| 01/16/2003 | US20030013154 Nucleotide sequeces coding polypeptide for use in the generation of somatomedins |
| 01/16/2003 | US20030013153 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013152 Nucleotide sequences coding polypeptide for use in human therapeutics |
| 01/16/2003 | US20030013151 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/16/2003 | US20030013149 Quantitative analysis |
| 01/16/2003 | US20030013148 Genration of preferential fusion polypeptides; obtain amino acid sequences, immobilize on solid supports, react, recover fusion polypeptide |
| 01/16/2003 | US20030013143 Methods for identifying vasoprotective agents |
| 01/16/2003 | US20030013139 Transgenic cells for use as diagnostic tools in genetic engineering |
| 01/16/2003 | US20030013132 Non-invasive localization of a light-emitting conjugate in a mammal |
| 01/16/2003 | US20030013131 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 01/16/2003 | US20030013122 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/16/2003 | US20030013119 Gustducin materials and methods |
| 01/16/2003 | US20030013108 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 01/16/2003 | US20030013106 CCL1 polynucleotides and polypeptides and uses thereof |
| 01/16/2003 | US20030013100 Nucleic acid reading and analysis system |
| 01/16/2003 | US20030013087 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/16/2003 | US20030013085 Production of replicative hepatitis C virus |
| 01/16/2003 | US20030013081 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 01/16/2003 | US20030013077 Binding to monoclonal antibodies; detection of Kaposi's sarcoma |
| 01/16/2003 | US20030013076 Viral vector for use as tool in genetic engineering and human therapeutics |
| 01/16/2003 | US20030013075 Diagnosing tumors in animal cells; obtain cells, detect expression of cancer marker gene, amplified concentration of marker gene expression indicates cancer |
| 01/16/2003 | US20030012819 Method of preparing biological materials and preparations produced using same |
| 01/16/2003 | US20030012795 Treating peripheral resistance in a mammal; modulating the immune response in a mammal |
| 01/16/2003 | US20030012790 Especially bispecific molecules comprising an IFN- gamma inhibitor and a further specificity to a target involved in the initiation or development of IBD, including ulcerative colitis and Crohn's disease. |
| 01/16/2003 | US20030012788 Determining activation of various molecules, such as JAK-1, Tyk2, to identify molecules which mediate this interaction by measuring the activity of one or more of the molecules in the pathway to identify agonists and antagonists. |
| 01/16/2003 | US20030012787 Especially for ulcerative colitis and Crohn's disease. |
| 01/16/2003 | US20030012780 Anti-inflammatory medicaments |
| 01/16/2003 | US20030012776 A nucleic acid sequence which encodes RIAZ protein; abolishing drug resistance in cancer cells; drug development assay; diagnosing and treating cancer; gene therapy; prediction of chemosensitivity in cancer patients |
| 01/16/2003 | US20030012775 PEG conjugates of NK4 |
| 01/16/2003 | US20030012770 Recombinant p53 adenovirus methods and compositions |
| 01/16/2003 | US20030012768 Connective tissue growth factor-2 |
| 01/16/2003 | US20030012766 Orally-administered interferon-tau compositions and methods |
| 01/16/2003 | US20030012741 Process for the preparation of micronised collagen, and its therapeutic applications |
| 01/16/2003 | US20030012734 Biodegradable hydrogel having a visualization agent that reflects or emits light at a wavelength detectable to a human eyeast partially disposed within the interior. |
| 01/16/2003 | US20030010715 Use of cationic exchange chromatography on solid matrix carried out at basic pH |
| 01/16/2003 | DE20023055U1 Photolithographic exposure unit for e.g. manufacturing DNA chips, scans target areas of biological material selectively with highly-focused flying spot illumination |
| 01/16/2003 | CA2812821A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences |
| 01/16/2003 | CA2812799A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences |
| 01/16/2003 | CA2785699A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | CA2467006A1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | CA2462951A1 Isolation and purification of plasmodium falciparum merozoite protein-142 |